Mirae Asset Global ETFs Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$122M Sell
874,834
-13,883
-2% -$1.94M 0.17% 132
2025
Q4
$109M Sell
888,717
-6,076
-0.7% -$738K 0.16% 139
2025
Q3
$99.3M Sell
894,793
-69,081
-7% -$7.85M 0.16% 137
2025
Q2
$107M Sell
963,874
-88,886
-8% -$9.46M 0.21% 108
2025
Q1
$118M Buy
1,052,760
+53,831
+5% +$5.55M 0.25% 85
2024
Q4
$92.3M Sell
998,929
-57,863
-5% -$5.21M 0.2% 110
2024
Q3
$88.6M Sell
1,056,792
-3,596
-0.3% -$274K 0.2% 106
2024
Q2
$72.8M Buy
+1,060,388
New +$70.8M 0.17% 126

Other funds holding GILD

Mirae Asset Global ETFs Holdings's GILD Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Gilead Sciences (GILD) stake by 1.6% in Q1 2026, selling an estimated $1.94M and leaving 874,834 shares worth $122M. The position accounts for 0.17% of the portfolio, ranked #132.

Mirae Asset Global ETFs Holdings first reported a position in GILD in Q2 2024 and has held it in 8 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 874,834 shares of Gilead Sciences worth $122M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 13,883 Gilead Sciences shares in Q1 2026, an estimated $1.94M.
  • Gilead Sciences made up 0.17% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #132 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Gilead Sciences in Q2 2024 and has held it in 8 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.